Poor
Needs Rework
Patient Risk:
Low
Summary
Only the general prevention-of-heart-disease/MI/stroke indication is supported by the provided label excerpts (Sections 1.1 and 14.1). Most other claims (alcohol interactions, bleeding risk, kidney damage, pregnancy/breastfeeding safety) are not supported or cannot be verified from the supplied label text, making the overall alignment poor.
Category Scores
Accurate Statements
Lipitor (atorvastatin) is used to prevent heart disease.
Supported by Section 1.1 (Prevention of Cardiovascular Disease), which indicates LIPITOR to reduce risk of myocardial infarction and stroke and to reduce revascularization procedures/angina in appropriate adult populations.
By reducing cholesterol production, Lipitor helps lower low-density lipoprotein (LDL) cholesterol in the blood.
Not supported by the provided label excerpts for evaluation (the supplied sections focus on cardiovascular prevention and clinical studies, not mechanism or LDL-lowering details).
Unsupported Statements
Lipitor (atorvastatin) is a medication used to lower cholesterol levels.
Not supported by the provided label excerpts (Sections 1 and 14.1 excerpts supplied do not describe cholesterol-lowering as a stated claim).
Lipitor is a statin that inhibits the production of cholesterol in the liver.
No mechanism-of-action text provided in the supplied excerpts to support this claim.
By reducing cholesterol production, Lipitor helps lower low-density lipoprotein (LDL) cholesterol in the blood.
No LDL-specific claim text provided in the supplied excerpts.
Drinking alcohol while taking Lipitor can increase the risk of liver damage.
No alcohol/liver damage interaction information provided in the supplied excerpts.
Drinking alcohol while taking Lipitor can increase the risk of muscle pain.
No alcohol/muscle pain interaction information provided in the supplied excerpts.
Combining Lipitor and alcohol can increase the risk of other adverse effects.
No alcohol/adverse effects interaction information provided in the supplied excerpts.
Lipitor can cause liver damage in some people.
No hepatotoxicity or liver damage adverse-effect warning text provided in the supplied excerpts.
Drinking alcohol can increase the risk of liver damage when combined with Lipitor.
No alcohol/liver interaction information provided in the supplied excerpts.
Lipitor can cause muscle pain and weakness in some people.
No myopathy/muscle adverse-effect information provided in the supplied excerpts.
Drinking alcohol can exacerbate muscle pain and weakness when combined with Lipitor.
No alcohol/myopathy interaction information provided in the supplied excerpts.
Lipitor can increase the risk of bleeding.
No bleeding-risk adverse effect information provided in the supplied excerpts.
Drinking alcohol can also increase the risk of bleeding when combined with Lipitor.
No alcohol/bleeding interaction information provided in the supplied excerpts.
Combining Lipitor and alcohol may increase likelihood of bleeding or bruising.
No alcohol/bleeding-bruising interaction information provided in the supplied excerpts.
Muscle pain or weakness, especially in the arms or legs, may be a sign of a Lipitor-and-alcohol interaction.
No interaction and no symptom guidance provided in the supplied excerpts.
Jaundice (yellowing of the skin or eyes), dark urine, or pale stools may be signs of liver damage from a Lipitor-and-alcohol interaction.
No alcohol interaction and no specific symptom guidance for liver injury provided in the supplied excerpts.
Bleeding or bruising easily may be a sign of a Lipitor-and-alcohol interaction.
No alcohol interaction and no bleeding/bruising symptom guidance provided in the supplied excerpts.
Avoid drinking alcohol while taking Lipitor to minimize interaction risk.
No alcohol-avoidance instruction provided in the supplied excerpts.
Limiting alcohol intake to moderate levels (up to one drink per day for women and up to two drinks per day for men) is recommended if drinking alcohol while taking Lipitor.
No alcohol quantity threshold guidance provided in the supplied excerpts.
Talking to a doctor is recommended if there are concerns about taking Lipitor and drinking alcohol.
No alcohol-specific counseling instruction provided in the supplied excerpts.
Lipitor can interact with other medications, including blood thinners.
No specific interaction list (including blood thinners) provided in the supplied excerpts.
Lipitor can interact with other medications, including certain antibiotics.
No specific interaction list provided in the supplied excerpts.
Lipitor can interact with other medications, including certain medications for high blood pressure.
No specific interaction list provided in the supplied excerpts.
Lipitor can increase the risk of liver damage in some people.
No liver damage risk wording provided in the supplied excerpts.
If a person has pre-existing liver disease, they may be at higher risk of liver damage from Lipitor.
No pre-existing liver disease risk statement provided in the supplied excerpts.
Lipitor typically starts working within a few weeks.
No onset-of-therapy timing provided in the supplied excerpts.
It may take several months to see the full effects of Lipitor.
No time-to-effect statement provided in the supplied excerpts.
If a person is pregnant or breastfeeding, they should talk to their doctor before taking Lipitor.
No pregnancy/breastfeeding counseling language provided in the supplied excerpts.
Lipitor is generally safe during pregnancy and breastfeeding.
No pregnancy/breastfeeding safety statements provided in the supplied excerpts.
Lipitor can cause kidney damage in some people.
No kidney damage adverse-effect information provided in the supplied excerpts.
If a person has pre-existing kidney disease, they may be at higher risk of kidney damage from Lipitor.
No pre-existing kidney disease risk statement provided in the supplied excerpts.
If a person has kidney disease, they should talk to their doctor before taking Lipitor.
No kidney-disease counseling guidance provided in the supplied excerpts.
Contradictions
Important Omissions
Specific FDA-label contraindications, boxed warning, and formal warnings/precautions (including whether any alcohol guidance exists) are not assessed because the supplied excerpts do not contain those sections.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only clearly supported label claim in the provided excerpts is cardiovascular risk reduction. However, several additional safety-related interaction and adverse-effect claims (alcohol-liver/muscle/bleeding, kidney damage, and pregnancy/breastfeeding safety) are unsupported by the supplied label text and could mislead readers if presented as label-accurate.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Needs Rework
Primary Issue
Many claims are not supported by the provided FDA label excerpts (notably alcohol interaction guidance, bleeding, kidney damage, pregnancy/breastfeeding safety, and timing of effect). Only the cardiovascular prevention indication is supported.
Suggested Improvement
Limit claims to what is explicitly supported by the provided label excerpts (e.g., Section 1.1 cardiovascular prevention indications). For alcohol, drug interactions, adverse reactions, and special populations, only state text that appears in the actual provided label sections (Warnings/Precautions, Drug Interactions, Adverse Reactions, and Use in Specific Populations).